Stazzone Peter

Lixte Biotechnology Holdings, Inc. · Chief Financial Officer

Stazzone Peter is listed in filings as Chief Financial Officer at Lixte Biotechnology Holdings, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2026, including 6 public disclosures. Recent filings connect the profile to Lixte Biotechnology Holdings, Inc. (LIXTW) and Lixte Biotechnology Holdings, Inc. (LIXT). The current snapshot covers public activity from Sep 4, 2025 to Apr 17, 2026. Reported amounts are shown as $222.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.